SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012946
Filing Date
2020-11-05
Accepted
2020-11-05 17:16:49
Documents
65
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q iova-20200930x10q.htm   iXBRL 10-Q 2159720
2 EX-31.1 iova-20200930xex31d1.htm EX-31.1 12237
3 EX-31.2 iova-20200930xex31d2.htm EX-31.2 12209
4 EX-32.1 iova-20200930xex32d1.htm EX-32.1 7006
5 EX-32.2 iova-20200930xex32d2.htm EX-32.2 7088
6 GRAPHIC iova-20200930x10q001.jpg GRAPHIC 70506
  Complete submission text file 0001558370-20-012946.txt   8123540

Data Files

Seq Description Document Type Size
7 EX-101.SCH iova-20200930.xsd EX-101.SCH 45738
8 EX-101.CAL iova-20200930_cal.xml EX-101.CAL 42029
9 EX-101.DEF iova-20200930_def.xml EX-101.DEF 201620
10 EX-101.LAB iova-20200930_lab.xml EX-101.LAB 368815
11 EX-101.PRE iova-20200930_pre.xml EX-101.PRE 334569
12 EXTRACTED XBRL INSTANCE DOCUMENT iova-20200930x10q_htm.xml XML 1507301
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 201291580
SIC: 2836 Biological Products, (No Diagnostic Substances)